Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The inhibition of
ribonuclease
Bi by 3'-
N-hydroxyurea
-3'-deoxythymidine 5'-phosphate is enhanced by 30-fold in the presence of Zn(2+). Thus, an
N-hydroxyurea
nucleotide can recruit Zn(2+) to inhibit the enzymatic activity of a
ribonuclease
. This result engenders a general strategy for the inhibition of non-metalloenzymes by metal complexes.
...
PMID:Zinc(II)-mediated inhibition of a ribonuclease by an N-hydroxyurea nucleotide. 1256 40
Ribonuclease Sa (RNase Sa) is a secretory
ribonuclease
from Streptomyces aureofaciens. Herein, 3'-
N-hydroxyurea
-3'-deoxythymidine 5'-phosphate is shown to be a competitive inhibitor of catalysis by RNase Sa. Inhibition is enhanced by nearly 10-fold in the presence of Zn(2+), which could coordinate to the
N-hydroxyurea
group along with enzymic residues. The carboxylate of Glu54 is the putative base that abstracts a proton from the 2' hydroxyl group during catalysis of RNA cleavage by RNase Sa. Replacing Glu54 with a glutamine residue has no effect on the affinity of
N-hydroxyurea
1 for the enzyme, but eliminates the zinc(II)-dependence of that affinity. These data indicate that an
N-hydroxyurea
nucleotide can recruit Zn(2+) to inhibit the enzymatic activity of RNase Sa, and suggest that the carboxylate of Glu54 is a ligand for that Zn(2+). These findings further the development of a new class of
ribonuclease
inhibitors based on the complex of an
N-hydroxyurea
nucleotide and zinc(II).
...
PMID:Zinc(II)-mediated inhibition of ribonuclease Sa by an N-hydroxyurea nucleotide and its basis. 1515 54